Pricing and Reimbursement Issues in the European Economic Area
| Autor: | Christopher J. S. Hodges |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
medicine.medical_specialty
Public economics business.industry Public health Member states Public Health Environmental and Occupational Health Pharmacology (nursing) Legislation Commission Drug Guides Development economics medicine media_common.cataloged_instance Pharmacology (medical) Business European union Reimbursement Health policy Pharmaceutical industry media_common |
| Zdroj: | Drug Information Journal. 31:251-258 |
| ISSN: | 2164-9200 0092-8615 |
| DOI: | 10.1177/009286159703100135 |
| Popis: | This paper examines the European Commission and Member States policies on balancing the competing interests of reducing national public health spending while encouraging the pharmaceutical industry to be competitive. Although the Commission set out to gradually harmonize pricing and reimbursement of pharmaceuticals, it was not able to do so due to resistance from Member States. Overall, national systems govern pricing and reimbursement; this is unlikely to change. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|